Chardan Capital Has Lowered Expectations for CRISPR Therapeutics (NASDAQ:CRSP) Stock Price
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price reduced by Chardan Capital from...
Your Source for Insightful Trends and Discussions.
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price reduced by Chardan Capital from...